Published in Immunotherapy Weekly, August 9th, 2006
Study 1: According to a study from Italy, hepatitis C virus (HCV)-associated lymphoproliferative disorders involve differing increases of interleukin (IL) inhibitors.
"HCV causes hepatitis, liver cirrhosis and hepatocellular carcinoma, and may also induce type II mixed cryoglobulinemia syndrome (MC), a disease characterized by clonal B-cell lymphoproliferations that can evolve into non-Hodgkin lymphoma (NHL)," wrote M. Libra and colleagues, University of Catania.
They continued, "IL-1 is a cytokine that plays an important role in initiating the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly
Source: Immunotherapy Weekly (2006-08-09)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.